The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2024

Filed:

Nov. 02, 2020
Applicant:

Sutro Biopharma, Inc., South San Francisco, CA (US);

Inventors:

Toni Kline, San Francisco, CA (US);

Qun Yin, Palo Alto, CA (US);

Krishna Bajjuri, Fremont, CA (US);

Assignee:

SUTRO BIOPHARMA, INC., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 5/083 (2006.01); C07K 5/02 (2006.01); A61K 47/68 (2017.01); C07K 9/00 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 16/40 (2006.01); C07K 5/065 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 5/0808 (2013.01); A61K 47/6817 (2017.08); C07K 5/0205 (2013.01); C07K 9/003 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 16/40 (2013.01); A61K 38/00 (2013.01); A61K 47/6855 (2017.08); C07K 5/06078 (2013.01); C07K 2317/76 (2013.01);
Abstract

Provided herein are hemiasterlin derivatives, conjugates thereof, compositions comprising the derivatives or conjugates thereof, methods of producing the derivatives and conjugates thereof, and methods of using the derivatives, conjugates, and compositions for the treatment of cell proliferation. The derivatives, conjugates, and compositions are useful in methods of treatment and prevention of cell proliferation and cancer, methods of detection of cell proliferation and cancer, and methods of diagnosis of cell proliferation and cancer. In an embodiment, the hemiasterlin derivatives are according to Formula 1000: or a pharmaceutically acceptable salt, solvate, or tautomer thereof, wherein Ar, L, W, W, W, SG, and R are as described herein.


Find Patent Forward Citations

Loading…